156 related articles for article (PubMed ID: 36316276)
1. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
Inserra A; Giorgini G; Lacroix S; Bertazzo A; Choo J; Markopolous A; Grant E; Abolghasemi A; De Gregorio D; Flamand N; Rogers G; Comai S; Silvestri C; Gobbi G; Di Marzo V
Br J Pharmacol; 2023 Mar; 180(6):721-739. PubMed ID: 36316276
[TBL] [Abstract][Full Text] [Related]
2. Alterations of brain endocannabinoidome signaling in germ-free mice.
Manca C; Shen M; Boubertakh B; Martin C; Flamand N; Silvestri C; Di Marzo V
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158786. PubMed ID: 32795503
[TBL] [Abstract][Full Text] [Related]
3. Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.
Inserra A; Campanale A; Cheishvili D; Dymov S; Wong A; Marcal N; Syme RA; Taylor L; De Gregorio D; Kennedy TE; Szyf M; Gobbi G
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110594. PubMed ID: 35777526
[TBL] [Abstract][Full Text] [Related]
4. Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice.
Lacroix S; Pechereau F; Leblanc N; Boubertakh B; Houde A; Martin C; Flamand N; Silvestri C; Raymond F; Di Marzo V; Veilleux A
mSystems; 2019 Dec; 4(6):. PubMed ID: 31848310
[TBL] [Abstract][Full Text] [Related]
5. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.
Manca C; Boubertakh B; Leblanc N; Deschênes T; Lacroix S; Martin C; Houde A; Veilleux A; Flamand N; Muccioli GG; Raymond F; Cani PD; Di Marzo V; Silvestri C
J Lipid Res; 2020 Jan; 61(1):70-85. PubMed ID: 31690638
[TBL] [Abstract][Full Text] [Related]
6. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.
De Gregorio D; Inserra A; Enns JP; Markopoulos A; Pileggi M; El Rahimy Y; Lopez-Canul M; Comai S; Gobbi G
Neuropsychopharmacology; 2022 May; 47(6):1188-1198. PubMed ID: 35301424
[TBL] [Abstract][Full Text] [Related]
7. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
[TBL] [Abstract][Full Text] [Related]
8. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Odland AU; Klein AK; Dowling G; Dempster NM; Wallach J; Passie T; Halberstadt AL
Drug Test Anal; 2020 Jun; 12(6):812-826. PubMed ID: 32180350
[TBL] [Abstract][Full Text] [Related]
9. Hypoabsorptive surgeries cause limb-dependent changes in the gut endocannabinoidome and microbiome in association with beneficial metabolic effects.
Mukorako P; St-Pierre DH; Flamand N; Biertho L; Lebel S; Lemoine N; Plamondon J; Roy MC; Tchernof A; Varin TV; Marette A; Silvestri C; Di Marzo V; Richard D
Int J Obes (Lond); 2023 Jul; 47(7):630-641. PubMed ID: 37142736
[TBL] [Abstract][Full Text] [Related]
10. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.
De Gregorio D; Popic J; Enns JP; Inserra A; Skalecka A; Markopoulos A; Posa L; Lopez-Canul M; Qianzi H; Lafferty CK; Britt JP; Comai S; Aguilar-Valles A; Sonenberg N; Gobbi G
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495318
[TBL] [Abstract][Full Text] [Related]
11. Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome.
Forteza F; Giorgini G; Raymond F
Cells; 2021 Apr; 10(4):. PubMed ID: 33920695
[TBL] [Abstract][Full Text] [Related]
12. Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome.
Shen M; Manca C; Suriano F; Nallabelli N; Pechereau F; Allam-Ndoul B; Iannotti FA; Flamand N; Veilleux A; Cani PD; Silvestri C; Di Marzo V
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011234
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
[TBL] [Abstract][Full Text] [Related]
14. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
Inserra A; De Gregorio D; Rezai T; Lopez-Canul MG; Comai S; Gobbi G
J Psychopharmacol; 2021 Apr; 35(4):469-482. PubMed ID: 33645311
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
Schindler EA; Harvey JA; Aloyo VJ
Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis.
Abolghasemi A; Manca C; Iannotti FA; Shen M; Leblanc N; Lacroix S; Martin C; Flamand N; Di Marzo V; Silvestri C
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830242
[TBL] [Abstract][Full Text] [Related]
17. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
Mardal M; Johansen SS; Thomsen R; Linnet K
Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
[TBL] [Abstract][Full Text] [Related]
19. Role of the 5-HT
Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
[TBL] [Abstract][Full Text] [Related]
20. Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects.
Strajhar P; Schmid Y; Liakoni E; Dolder PC; Rentsch KM; Kratschmar DV; Odermatt A; Liechti ME
J Neuroendocrinol; 2016 Mar; 28(3):12374. PubMed ID: 26849997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
